Literature DB >> 13739760

Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

O D RATNOFF, E W DAVIE, D L MALLETT.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION

Mesh：

Substances：

Year:  1961        PMID： 13739760      PMCID： PMC290792          DOI： 10.1172/JCI104314

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  32 in total

1.  Hageman trait and PTA deficiency; the role of contact of blood with glass.

Authors:  J P SOULIER; O WARTELLE; D MENACHE
Journal:  Br J Haematol       Date:  1959-01       Impact factor: 6.998

2.  Surface activation of plasma clotting: a function of Hageman factor.

Authors:  C L JOHNSTON; J H FERGUSON; F A O'HANLON
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

3.  A method for assay of Stuart factor.

Authors:  H S SISE; S M LAVELLE; R BECKER
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

4.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

5.  Molecular-kinetic properties of crystalline diisopropyl phosphoryl trypsin.

Authors:  L W CUNNINGHAM
Journal:  J Biol Chem       Date:  1954-11       Impact factor: 5.157

6.  New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.

Authors:  R L ROSENTHAL; O H DRESKIN; N ROSENTHAL
Journal:  Proc Soc Exp Biol Med       Date:  1953-01

7.  Molecular-kinetic properties of crystalline trypsinogen.

Authors:  F TIETZE
Journal:  J Biol Chem       Date:  1953-09       Impact factor: 5.157

8.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

9.  THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN".

Authors:  C L Conley; R C Hartmann; W I Morse
Journal:  J Clin Invest       Date:  1949-03       Impact factor: 14.808

10.  Observations on hemophilia, parahemophilia, and coexistent hemophilia and parahemophilia; alterations in the platelets and the thromboplastin generation test.

Authors:  R H SEIBERT; A MARGOLIUS; O D RATNOFF
Journal:  J Lab Clin Med       Date:  1958-09
View more
  40 in total

Review 1.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

2.  Partial purification and characterization of contact activation cofactor.

Authors:  S Schiffman; P Lee
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

Review 3.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

4.  THE INDUCTION OF PERMEABILITY-INCREASING ACTIVITY IN HUMAN PLASMA BY ACTIVATED HAGEMAN FACTOR.

Authors:  O D RATNOFF; A A MILES
Journal:  Br J Exp Pathol       Date:  1964-06

5.  THE CLOT-PROMOTING EFFECT OF SOAPS OF LONG-CHAIN SATURATED FATTY ACIDS.

Authors:  R E BOTTI; O D RATNOFF
Journal:  J Clin Invest       Date:  1963-10       Impact factor: 14.808

6.  Massive thrombosis produced by fatty acid infusion.

Authors:  W E CONNOR; J C HOAK; E D WARNER
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

7.  The thrombotic activity of activation product.

Authors:  E S HENDERSON; S L RAPAPORT
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

8.  Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system.

Authors:  S G IATRIDIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808

9.  The Role of Proaccelerin in Human Blood Coagulation. Evidence that Proaccelerin Is Converted to a Prothrombin-converting Principle by Activated Stuart Factor: With Notes on the Anticoagulant Action of Soybean Trypsin Inhibitor, Protamine Sulfate, and Hexadimethrine Bromide.

Authors:  R T Breckenridge; O D Ratnoff
Journal:  J Clin Invest       Date:  1965-02       Impact factor: 14.808

10.  THE ACCELERATION OF THROMBUS FORMATION BY CERTAIN FATTY ACIDS.

Authors:  W E Connor
Journal:  J Clin Invest       Date:  1962-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.